IBDEI0ZQ ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16468,1,3,0)
 ;;=3^Presence of Prostetic Heart Valve
 ;;^UTILITY(U,$J,358.3,16468,1,4,0)
 ;;=4^Z95.2
 ;;^UTILITY(U,$J,358.3,16468,2)
 ;;=^5063670
 ;;^UTILITY(U,$J,358.3,16469,0)
 ;;=Z95.3^^88^847^68
 ;;^UTILITY(U,$J,358.3,16469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16469,1,3,0)
 ;;=3^Presence of Xenogenic Heart Valve
 ;;^UTILITY(U,$J,358.3,16469,1,4,0)
 ;;=4^Z95.3
 ;;^UTILITY(U,$J,358.3,16469,2)
 ;;=^5063671
 ;;^UTILITY(U,$J,358.3,16470,0)
 ;;=I27.9^^88^847^69
 ;;^UTILITY(U,$J,358.3,16470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16470,1,3,0)
 ;;=3^Pulmonary Heart Disease,Unspec
 ;;^UTILITY(U,$J,358.3,16470,1,4,0)
 ;;=4^I27.9
 ;;^UTILITY(U,$J,358.3,16470,2)
 ;;=^5007154
 ;;^UTILITY(U,$J,358.3,16471,0)
 ;;=I27.0^^88^847^70
 ;;^UTILITY(U,$J,358.3,16471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16471,1,3,0)
 ;;=3^Pulmonary Hypertension,Primary
 ;;^UTILITY(U,$J,358.3,16471,1,4,0)
 ;;=4^I27.0
 ;;^UTILITY(U,$J,358.3,16471,2)
 ;;=^265310
 ;;^UTILITY(U,$J,358.3,16472,0)
 ;;=I73.00^^88^847^71
 ;;^UTILITY(U,$J,358.3,16472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16472,1,3,0)
 ;;=3^Raynaud's Syndrome w/o Gangrene
 ;;^UTILITY(U,$J,358.3,16472,1,4,0)
 ;;=4^I73.00
 ;;^UTILITY(U,$J,358.3,16472,2)
 ;;=^5007796
 ;;^UTILITY(U,$J,358.3,16473,0)
 ;;=R57.0^^88^847^72
 ;;^UTILITY(U,$J,358.3,16473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16473,1,3,0)
 ;;=3^Shock,Cardiogenic
 ;;^UTILITY(U,$J,358.3,16473,1,4,0)
 ;;=4^R57.0
 ;;^UTILITY(U,$J,358.3,16473,2)
 ;;=^5019525
 ;;^UTILITY(U,$J,358.3,16474,0)
 ;;=R57.1^^88^847^73
 ;;^UTILITY(U,$J,358.3,16474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16474,1,3,0)
 ;;=3^Shock,Hypovolemic
 ;;^UTILITY(U,$J,358.3,16474,1,4,0)
 ;;=4^R57.1
 ;;^UTILITY(U,$J,358.3,16474,2)
 ;;=^60845
 ;;^UTILITY(U,$J,358.3,16475,0)
 ;;=R57.9^^88^847^74
 ;;^UTILITY(U,$J,358.3,16475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16475,1,3,0)
 ;;=3^Shock,Unspec
 ;;^UTILITY(U,$J,358.3,16475,1,4,0)
 ;;=4^R57.9
 ;;^UTILITY(U,$J,358.3,16475,2)
 ;;=^5019527
 ;;^UTILITY(U,$J,358.3,16476,0)
 ;;=R55.^^88^847^75
 ;;^UTILITY(U,$J,358.3,16476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16476,1,3,0)
 ;;=3^Syncope and Collapse
 ;;^UTILITY(U,$J,358.3,16476,1,4,0)
 ;;=4^R55.
 ;;^UTILITY(U,$J,358.3,16476,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,16477,0)
 ;;=I78.0^^88^847^76
 ;;^UTILITY(U,$J,358.3,16477,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16477,1,3,0)
 ;;=3^Telangiectasia,Hereditary Hemorrhagic
 ;;^UTILITY(U,$J,358.3,16477,1,4,0)
 ;;=4^I78.0
 ;;^UTILITY(U,$J,358.3,16477,2)
 ;;=^117566
 ;;^UTILITY(U,$J,358.3,16478,0)
 ;;=I73.1^^88^847^20
 ;;^UTILITY(U,$J,358.3,16478,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16478,1,3,0)
 ;;=3^Buerger's Disease
 ;;^UTILITY(U,$J,358.3,16478,1,4,0)
 ;;=4^I73.1
 ;;^UTILITY(U,$J,358.3,16478,2)
 ;;=^5007798
 ;;^UTILITY(U,$J,358.3,16479,0)
 ;;=G45.9^^88^847^77
 ;;^UTILITY(U,$J,358.3,16479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16479,1,3,0)
 ;;=3^Transient Cerebral Ischemic Attack,Unspec
 ;;^UTILITY(U,$J,358.3,16479,1,4,0)
 ;;=4^G45.9
 ;;^UTILITY(U,$J,358.3,16479,2)
 ;;=^5003959
 ;;^UTILITY(U,$J,358.3,16480,0)
 ;;=G45.8^^88^847^78
 ;;^UTILITY(U,$J,358.3,16480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16480,1,3,0)
 ;;=3^Transient Cerebral Ischemic Attacks & Related Syndromes
 ;;^UTILITY(U,$J,358.3,16480,1,4,0)
 ;;=4^G45.8
 ;;^UTILITY(U,$J,358.3,16480,2)
 ;;=^5003958
 ;;^UTILITY(U,$J,358.3,16481,0)
 ;;=I83.019^^88^847^81
 ;;^UTILITY(U,$J,358.3,16481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16481,1,3,0)
 ;;=3^Varicose Veins Right Lower Extrem w/ Ulcer Unspec Site
